AnaptysBio, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: San Diego CA United States (2005)

Organization Overview

First Clinical Trial
2016
NCT02920021
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

AnaptysBio, Inc.